Kunath, B., Hickl, O., Teixeira Queiros, P., Martin-Gallausiaux, C., Lebrun, L., Halder, R., Laczny, C. C., Schmidt, T. S., Hayward, M., Becher, D., Heintz-Buschart, A., de Beaufort, C., Bork, P., May, P., & Wilmes, P. (2022). Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses. Microbiome. doi:10.1186/s40168-022-01435-4 Peer Reviewed verified by ORBi |
de Beaufort, C., Schierloh, U., Thankamony, A., Ware, J., Wilinska, M. E., Fröhlich-Reiterer, E., Kapellen, T. M., Rami-Merhar, Hofer, S. E., Campbell, F. M., Bocchino, L. E., Lawton, J., Rioze, S., Hood, K., Frisch, M., Thiele, A., Allen, J., Boughton, C., Hovorka, R., & Pit-Ten Cate, I. (04 October 2022). Cambridge hybrid closed-loop system in very young children with type 1 diabetes reduces caregivers’ fear of hypoglycemia and improves their well-being. Diabetes Care, 45, 3050-3053. doi:10.2337/dc22-0693 Peer Reviewed verified by ORBi |
Schmidt, T., Hayward, M., Coelho, L., Li, S., Costea, P., Voigt, A., Wirbel, J., Maistrenko, O., Alves, R., Bergsten, E., de Beaufort, C., Sobhani, I., Heintz, A., Sunagawa, S., Zeller, G., Wilmes, P., & Bork, P. (2019). Extensive transmission of microbes along the gastrointestinal tract. eLife. doi:10.7554/eLife.42693 Peer Reviewed verified by ORBi |
Wampach, L., Heintz, A., Fritz, J., Ramiro Garcia, J., Habier, J., Herold, M., Narayanasamy, S., Kaysen, A., Hogan, A., Bindl, L., Bottu, J., Halder, R., Sjöqvist, C., May, P., Andersson, A., de Beaufort, C., & Wilmes, P. (2018). Birth mode is associated with earliest strain-conferred gut microbiome functions and immunostimulatory potential. Nature Communications. doi:10.1038/s41467-018-07631-x Peer Reviewed verified by ORBi |
Wampach, L., Heintz, A., Hogan, A., Muller, E., Narayanasamy, S., Laczny, C. C., Hugerth, L., Bindl, L., Bottu, J., Andersson, A., de Beaufort, C., & Wilmes, P. (2017). Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life. Frontiers in Microbiology. doi:10.3389/fmicb.2017.00738 Peer Reviewed verified by ORBi |
Hornig, N. C., De Beaufort, C., Denzer, F., Cools, M., Wabitsch, Ukat, M., Kulle, A. E., Schweikert, H. U., Werner, R., Hiort, O., Audi, L., Siebert, R., Ammerpohl, O., & Holterhus, P. M. (25 April 2016). A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation. PLoS ONE, 11 (4). doi:10.1371/journal.pone.0154158 Peer Reviewed verified by ORBi |
Laczny, C. C., Muller, E., Heintz, A., Herold, M., Lebrun, L., Hogan, A., May, P., de Beaufort, C., & Wilmes, P. (2016). Identification, recovery, and refinement of hitherto undescribed population-level genomes from the human gastrointestinal tract. Frontiers in Microbiology, 7 (884). doi:10.3389/fmicb.2016.00884 Peer Reviewed verified by ORBi |
Kaur, S., Mirza, A. H., Brorsson, C. A., Fløyel, T., Størling, J., Mortensen, H. B., Pociot, F., Aanstoot, H.-J., De Beaufort, C., Cameron, F., Castano, L., Dorchy, H., Fisher, L., Kaprio, E., Lange, K., Neu, A., Njolstad, P. R., Phillip, M., Urukami, T., ... Robert, J. J. (2016). The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus. Molecular and Cellular Endocrinology, 419, 83-91. doi:10.1016/j.mce.2015.10.002 Peer reviewed |
Heintz, A., May, P., Laczny, C. C., Lebrun, L., Bellora, C., Krishna, A., Wampach, L., Schneider, J., Hogan, A., de Beaufort, C., & Wilmes, P. (2016). Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nature Microbiology, 2, 16180. doi:10.1038/NMICROBIOL.2016.180 Peer Reviewed verified by ORBi |
Patterson, C., Gyürüs, E., Rosenbauer, J., Cinek, O., Neu, A., Schober, E., Parslow, R., Joner, G., Svensson, J., Castell, C., Bingley, P., Schoenle, E., Jarosz-Chobot, P., Urbonaité, B., Rothe, U., Kržišnik, C., Ionescu-Tirgoviste, C., Weets, I., Kocova, M., ... Dahlquist, G. (December 2015). Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature. Pediatric Diabetes, 16 (8), 573-580. doi:10.1111/pedi.12227 Peer Reviewed verified by ORBi |
Samouda, H., De Beaufort, C., Stranges, S., Guinhouya, B. C., Gilson, G., Hirsch, M., Jacobs, J., Leite, S., Vaillant, M., & Dadoun, F. (24 October 2015). Adding anthropometric measures of regional adiposity to BMI improves prediction of cardiometabolic, inflammatory and adipokines profiles in youths: a cross-sectional study. BMC Pediatrics, 15, 168. doi:10.1186/s12887-015-0486-5 Peer Reviewed verified by ORBi |
Samouda, H., De Beaufort, C., Stranges, S., Hirsch, M., Van Nieuwenhuyse, J.-P., Dooms, G., Gilson, G., Keunen, O., Leite, S., Vaillant, M., Lair, M.-L., & Dadoun, F. (2015). Cardiometabolic risk: leg fat is protective during childhood. Pediatric Diabetes. doi:10.1111/pedi.12292 Peer Reviewed verified by ORBi |
Wampach, L., Buschart, A., Hogan, A., Bindl, L., Bottu, J., Schneider, J., de Beaufort, C., & Wilmes, P. (June 2015). Early dynamics of the gastrointestinal microbiome in infants at risk of metabolic disease in adulthood [Poster presentation]. The Human Microbiome, Heidelberg, Germany. |
Buschart, A., May, P., Laczny, C. C., Lebrun, L., Wampach, L., Hogan, A., Schneider, J., de Beaufort, C., & Wilmes, P. (March 2015). Integrated omics analyses of the human gut microbiome in a multiplex family study of type 1 diabetes mellitus [Poster presentation]. 5th International Human Microbiome Congress, Luxembourg-City, Luxembourg. |
Wampach, L., Buschart, A., Hogan, A., Bindl, L., Bottu, J., Schneider, J., de Beaufort, C., & Wilmes, P. (March 2015). Early dynamics of the gastrointestinal microbiome in infants at risk of metabolic disease in adulthood [Poster presentation]. 5th International Human Microbiome Congress, Luxembourg-City, Luxembourg. |
Neu, A., Lange, K., Barrett, T., Cameron, F., Dorchy, H., Hoey, H., Jarosz-Chobot, P., Mortensen, H. B., Robert, J.-J., Robertson, K., & De Beaufort, C. (2015). Classifying insulin regimens--difficulties and proposal for comprehensive new definitions. Pediatric Diabetes, 16 (6), 402-406. doi:10.1111/pedi.12275 Peer Reviewed verified by ORBi |
Knip, M., Åkerblom, H. K., Becker, D., Dosch, H. M., Dupre, J., Fraser, W., Howard, N., Ilonen, J., Krischer, J. P., Kordonouri, O., Lawson, M. L., Palmer, J. P., Savilahti, E., Vaarala, O., Virtanen, S. M., & De Beaufort, C. (11 June 2014). Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA: Journal of the American Medical Association, 311 (22), 2279-2287. doi:10.1001/jama.2014.5610 Peer Reviewed verified by ORBi |
Heintz, A., May, P., Laczny, C. C., Lebrun, L., Wampach, L., Hogan, A., Schneider, J., Wilmes, P., & De Beaufort, C. (30 April 2014). Integrated Omic Analyses of the Human Gut Microbiome in a Multiplex Family Study of Type 1 Diabetes Mellitus [Poster presentation]. EMBO|EMBL Symposium: Translating Diabetes. |
Cameron, F. J., Amin, R., De Beaufort, C., Codner, E., & Acerini, C. L. (2014). Diabetes in adolescence. Pediatric Diabetes, 15 Suppl 20, 245-256. doi:10.1111/pedi.12169 Peer Reviewed verified by ORBi |
Karres, J., Pratt, V., Guettier, J.-M., Temeck, J., Tamborlane, W. V., Dunger, D., Bejnariu, C., De Beaufort, C., & Tomasi, P. (2014). Joining forces: a call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes. Diabetes Care, 37 (10), 2665-2667. doi:10.2337/dc14-0494 Peer Reviewed verified by ORBi |
Acerini, C., Craig, M. E., De Beaufort, C., Maahs, D. M., & Hanas, R. (2014). Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Pediatric Diabetes, 15 Suppl 20, 1-3. doi:10.1111/pedi.12182 Peer Reviewed verified by ORBi |
Acerini, C. L., Craig, M. E., De Beaufort, C., Maahs, D. M., Pillay, K., & Hanas, R. (2014). Introduction to the Limited Care Guidance Appendix to ISPAD Clinical Practice Consensus Guidelines 2014. Pediatric Diabetes, 15 Suppl 20, 279-80. doi:10.1111/pedi.12185 Peer Reviewed verified by ORBi |
Rewers, M. J., Pillay, K., De Beaufort, C., Craig, M. E., Hanas, R., Acerini, C. L., & Maahs, D. M. (2014). Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatric Diabetes, 15 Suppl 20, 102-114. doi:10.1111/pedi.12190 Peer Reviewed verified by ORBi |
Hommel, E., Olsen, B., Battelino, T., Conget, I., Schütz-Fuhrmann, I., Hoogma, R., Schierloh, U., Sulli, N., Gough, H., Castañeda, J., De Portu, S., Bolinder, J., & De Beaufort, C. (2014). Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetologica, 51 (5), 845-851. doi:10.1007/s00592-014-0598-7 Peer Reviewed verified by ORBi |
Lehtonen, E., Ormisson, A., Nucci, A., Cuthbertson, D., Sorkio, S., Hyytinen, M., Alahuhta, K., Berseth, C., Salonen, M., Taback, S., Franciscus, M., González-Frutos, T., Korhonen, T. E., Lawson, M. L., Becker, D. J., Krischer, J. P., Knip, M., Virtanen, S. M., & De Beaufort, C. (2014). Use of vitamin D supplements during infancy in an international feeding trial. Public Health Nutrition, 17 (4), 810-822. doi:10.1017/S1368980013001122 Peer Reviewed verified by ORBi |
Franciscus, M., Nucci, A., Bradley, B., Suomalainen, H., Greenberg, E., Laforte, D., Kleemola, P., Hyytinen, M., Salonen, M., Martin, M. J., Catte, D., Catteau, J., & De Beaufort, C. (Other coll.). (2014). Recruitment and retention of participants for an international type 1 diabetes prevention trial: a coordinators' perspective. Clinical Trials: Journal of the Society for Clinical Trials, 11 (2), 150-8. doi:10.1177/1740774513510070 Peer Reviewed verified by ORBi |
Eifes, S., Chudasama, K. K., Molnes, J., Wagner, K., Hoang, T., Schierloh, U., Rocour-Brumioul, D., Johansson, S., Njolstad, P. R., & De Beaufort, C. (December 2013). A novel GATA6 mutation in a child with congenital heart malformation and neonatal diabetes. Clinical Case Reports, 1 (2), 86-90. doi:10.1002/ccr3.33 Peer Reviewed verified by ORBi |
Due, P., De Beaufort, C., Damsgaard, M. T., Mortensen, H. B., Rasmussen, M., Ahluwalia, N., Skinner, T., & Swift, P. (December 2013). Do eating behaviors in the general population account for country variance in glycemic control among adolescents with diabetes: the Hvidoere Study Group and the Health Behaviour in School-Aged Children study. Pediatric Diabetes, 14 (8), 554-561. doi:10.1111/pedi.12038 Peer Reviewed verified by ORBi |
Wampach, L., Wilmes, P., & De Beaufort, C. (2013). Microbiome and type 1 diabetes. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/15192. doi:10.14496/dia.2104723411.14 |
Cameron, F. J., De Beaufort, C., Aanstoot, H.-J., Hoey, H., Lange, K., Castano, L., Mortensen, H. B., Aman, J., Atchison, J. A., Barret, T., Bjoernedalen, H., Castro-Correia, C., Chiarelli, F., Chiari, G., Dahl-Jørgensen, K., Daneman, D., Danne, T., Dorchy, H., Fisher, L., ... Vanelli, M. (November 2013). Lessons from the Hvidoere International Study Group on childhood diabetes: Be dogmatic about outcome and flexible in approach. Pediatric Diabetes, 14 (7), 473-480. doi:10.1111/pedi.12036 Peer reviewed |
Guinhouya, B. C., Fairclough, S. J., Zitouni, D., Samouda, H., Vilhelm, C., Zgaya, H., De Beaufort, C., Lemdani, M., & Hubert, H. (November 2013). Does biological maturity actually confound gender-related differences in physical activity in preadolescence? Child: Care, Health and Development, 39 (6), 835-844. doi:10.1111/j.1365-2214.2012.01407.x Peer Reviewed verified by ORBi |
Heintz, A., May, P., Lebrun, L., Ferrand, J., Trezzi, J.-P., Collignon, S., Wampach, L., Glaab, E., Laczny, C. C., Martins Conde, P., Kaysen, A., Schneider, J., Hiller, K., Hogan, A., Wilmes, P., & de Beaufort, C. (October 2013). Meta-omic Analyses of the Microbiome in a Family Study of Diabetes Mellitus [Poster presentation]. 2nd International Systems Biomedicine Symposium, Belval, Luxembourg. |
El Aarbaoui, T., Samouda, H., Zitouni, D., Di Pompeo, C., De Beaufort, C., Trincaretto, F., Mormentyn, A., Hubert, H., Lemdani, M., & Guinhouya, B. C. (September 2013). Does the body adiposity index (BAI) apply to paediatric populations? Annals of Human Biology, 40 (5), 451-458. doi:10.3109/03014460.2013.802011 Peer reviewed |
Guinhouya, B. C., Samouda, H., & De Beaufort, C. (April 2013). Level of physical activity among children and adolescents in Europe: A review of physical activity assessed objectively by accelerometry. Public Health, 127 (4), 301-311. doi:10.1016/j.puhe.2013.01.020 Peer reviewed |
Drewniak, A., Gazendam, R. P., Tool, A. T. J., van Houdt, M., Jansen, M. H., van Hamme, J. L., van Leeuwen, E. M. M., Roos, D., Scalais, E., De Beaufort, C., Janssen, H., van den Berg, T. K., & Kuijpers, T. W. (28 March 2013). Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood, 121 (13), 2385-2392. doi:10.1182/blood-2012-08-450551 Peer Reviewed verified by ORBi |
Di Iorio, C. T., Carinci, F., Brillante, M., Azzopardi, J., Beck, P., Bratina, N., Cunningham, S. G., De Beaufort, C., Debacker, N., Jarosz-Chobot, P., Jecht, M., Lindblad, U., Moulton, T., Metelko, Ž., Nagy, A., Olympios, G., Pruna, S., Røder, M., Skeie, S., ... Massi Benedetti, M. (2013). Cross-border flow of health information: is 'privacy by design' enough? Privacy performance assessment in EUBIROD. European Journal of Public Health, 23 (2), 247-253. doi:10.1093/eurpub/cks043 Peer Reviewed verified by ORBi |
Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., Bolinder, J., & De Beaufort, C. (December 2012). The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia, 55 (12), 3155-3162. doi:10.1007/s00125-012-2708-9 Peer Reviewed verified by ORBi |
Cardwell, C. R., Stene, L. C., Ludvigsson, J., Rosenbauer, J., Cinek, O., Svensson, J., Perez-Bravo, F., Memon, A., Gimeno, S. G., Wadsworth, E. J., Strotmeyer, E. S., Goldacre, M. J., Radon, K., Chuang, L. M., Parslow, R. C., Chetwynd, A., Karavanaki, K., Brigis, G., Pozzilli, P., ... Patterson, C. C. (November 2012). Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care, 35 (11), 2215-2225. doi:10.2337/dc12-0438 Peer Reviewed verified by ORBi |
De Beaufort, C., Lange, K., Swift, P. G., Aman, J., Cameron, F., Castano, L., Dorchy, H., Fisher, L. K., Hoey, H., Kaprio, E., Kocova, M., Neu, A., Njolstad, P. R., Phillip, M., Schoenle, E., Robert, J. J., Urukami, T., Vanelli, M., Danne, T., ... Mortensen, H. B. (September 2012). Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009. Pediatric Diabetes, 14 (6), 422-428. doi:10.1111/j.1399-5448.2012.00922.x Peer Reviewed verified by ORBi |
Forsander, G., Pellinat, M., Volk, M., Muller, M., Pinelli, L., Magnen, A., Danne, T., Aschemeier, B., & De Beaufort, C. (September 2012). Technical solution for data collection, data safety and data privacy legislation: experiences from the SWEET study. Pediatric Diabetes, 13 (16), 39-48. doi:10.1111/j.1399-5448.2012.00911.x Peer Reviewed verified by ORBi |
Danne, T., Aschemeier, B., Perfetti, R., & De Beaufort, C. (Other coll.). (September 2012). SWEET--where are we heading with international type 1 diabetes registries? Pediatric Diabetes, 13 (16), 1-4. doi:10.1111/j.1399-5448.2012.00906.x Peer Reviewed verified by ORBi |
Lange, K., Klotmann, S., Saßmann, H., Aschemeier, B., Wintergerst, E., Gerhardsson, P., Kordonouri, O., Szypowska, A., Danne, A., & De Beaufort, C. (Other coll.). (September 2012). A pediatric diabetes toolbox for creating centres of reference. Pediatric Diabetes, 13 (16), 49-61. doi:10.1111/j.1399-5448.2012.00913.x Peer Reviewed verified by ORBi |
Waldron, S., Rurik, I., Madacsy, L., Donnasson-Eudes, S., Rosu, M., Skovlund, S. E., Pankowska, E., Allgrove, J., & De Beaufort, C. (Other coll.). (September 2012). Good practice recommendations on paediatric training programmes for health care professionals in the EU. Pediatric Diabetes, 13 (16), 29-38. doi:10.1111/j.1399-5448.2012.00910.x Peer Reviewed verified by ORBi |
Danne, T., Lion, S., Madaczy, L., Veeze, H., Raposo, F., Rurik, I., Aschemeier, B., Kordonouri, O., & De Beaufort, C. (Other coll.). (September 2012). Criteria for Centers of Reference for pediatric diabetes--a European perspective. Pediatric Diabetes, 13 (16), 62-75. doi:10.1111/j.1399-5448.2012.00914.x Peer Reviewed verified by ORBi |
Martin, D., Lange, K., Sima, A., Kownatka, D., Skovlund, S., Danne, T., Robert, J. J., & De Beaufort, C. (Other coll.). (September 2012). Recommendations for age-appropriate education of children and adolescents with diabetes and their parents in the European Union. Pediatric Diabetes, 13 (16), 20-28. doi:10.1111/j.1399-5448.2012.00909.x Peer Reviewed verified by ORBi |
Cinek, O., Šumník, Z., De Beaufort, C., Rurik, I., Vazeou, A., Madácsy, L., Papo, N. L., & Danne, T. (September 2012). Heterogeneity in the systems of pediatric diabetes care across the European Union. Pediatric Diabetes, 13 (SUPPL. 16), 5-14. doi:10.1111/j.1399-5448.2012.00907.x Peer Reviewed verified by ORBi |
Patterson, C. C., Gyürüs, E., Rosenbauer, J., Cinek, O., Neu, A., Schober, E., Parslow, R. C., Joner, G., Svensson, J., Castell, C., Bingley, P. J., Schoenle, E., Jarosz-Chobot, Urbonaité, B., Rothe, U., Krzisnik, C., Ionescu-Tirgoviste, C., Weets, I., Kocova, M., ... Soltész, G. (August 2012). Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia, 55 (8), 2142-2147. doi:10.1007/s00125-012-2571-8 Peer Reviewed verified by ORBi |
Kaas, A., Max Andersen, M. L., Fredheim, S., Hougaard, P., Buschard, K., Petersen, J. S., De Beaufort, C., Robertson, K. J., Hansen, L., Mortensen, H. B., Nielsen, L. B., Aanstoot, H.-J., De Beaufort, C., Chiarelli, F., Dahl-Jørgensen, K., Göthner, H. B., Danne, T., Garandeau, P., Greene, S. A., ... Åman, J. (February 2012). Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes. Pediatric Diabetes, 13 (1), 51-58. doi:10.1111/j.1399-5448.2011.00812.x Peer reviewed |
Nucci, A. M., Becker, D. J., Virtanen, S. M., Cuthbertson, D., Softness, B., Huot, C., Wasikowa, R., Dosch, H. M., Akerblom, H. K., Knip, M., & De Beaufort, C. (Other coll.). (2012). Growth differences between North American and European children at risk for type 1 diabetes. Pediatric Diabetes. doi:10.1111/j.1399-5448.2011.00840.x Peer Reviewed verified by ORBi |
Kusters, D. M., De Beaufort, C., Widhalm, K., Guardamagna, O., Bratina, N., Ose, L., & Wiegman, A. (2012). Paediatric screening for hypercholesterolaemia in Europe. Archives of Disease in Childhood, 97 (3), 272-276. doi:10.1136/archdischild-2011-300081 Peer reviewed |
Phillip, M., Danne, T., Shalitin, S., Buckingham, B., Laffel, L., Tamborlane, W., Battelino, T., Hanas, R., Chase, P. H., O'Riordan, S., Fisher, L., Skyler, J., Jarosz-Chobot, P., Schober, E., De Beaufort, C., Fox, L., & Kordonouri, O. (2012). Use of continuous glucose monitoring in children and adolescents. Pediatric Diabetes, 13 (3), 215-228. doi:10.1111/j.1399-5448.2011.00849.x Peer reviewed |
De Beaufort, C., Vazeou, A., Sumnik, Z., Cinek, O., Hanas, R., Danne, T., Aschemeier, B., & Forsander, G. (2012). Harmonize care to optimize outcome in children and adolescents with diabetes mellitus: treatment recommendations in Europe. Pediatric Diabetes, 13 Suppl 16, 15-9. doi:10.1111/j.1399-5448.2012.00908.x Peer Reviewed verified by ORBi |
Cardwell, C. R., Svensson, J., Waldhoer, T., Ludvigsson, J., Sadauskaite-Kuehne, V., Roberts, C. L., Parslow, R. C., Wadsworth, E. J., Brigis, G., Urbonaite, B., Schober, E., Devoti, G., Ionescu-Tirgoviste, C., De Beaufort, C., Soltesz, G., & Patterson, C. C. (2012). Interbirth Interval Is Associated With Childhood Type 1 Diabetes Risk. Diabetes, 61 (3), 702-707. doi:10.2337/db11-1000 Peer Reviewed verified by ORBi |
De Beaufort, C., & Barnard, K. (2012). Challenges to emotional well being : depression, anxiety and parental fear of hypoglycaemia. In D. Christie & C. Martin (Eds.), Psychosocial Aspects of Diabetes: Children, Adolescents and Their Families. CRC Press. Peer reviewed |
Gies, I., Thomas, M., Tenoutasse, S., De Waele, K., Lebrethon, M. C., Beckers, D., Francois, I., Maes, M., Rooman, R., De Beaufort, C., Massa, G., & De Schepper, J. (2012). Insulin sensitivity modulates the growth response during the first year of high-dose growth hormone treatment in short prepubertal children born small for gestational age. Hormone Research in Paediatrics, 78 (1), 24-30. doi:10.1159/000339829 Peer Reviewed verified by ORBi |
Kaas, A., Pfleger, C., Kharagjitsingh, A. V., Schloot, N. C., Hansen, L., Buschard, K., Koeleman, B. P., Roep, B. O., Mortensen, H. B., Alizadeh, B. Z., & De Beaufort, C. (2011). Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes. Diabetic Medicine: A Journal of the British Diabetic Association. doi:10.1111/j.1464-5491.2011.03544.x Peer Reviewed verified by ORBi |
Knip, M., Virtanen, S. M., Becker, D., Dupré, J., Krischer, J. P., Åkerblom, H. K., & De Beaufort, C. (Other coll.). (December 2011). Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR). American Journal of Clinical Nutrition, 96 (6), 1814S-1820. doi:10.3945/ajcn.110.000711 Peer reviewed |
Nielsen, L. B., Vaziri-Sani, F., Pörksen, S., Andersen, M.-L. M., Svensson, J., Bergholdt, R., Pociot, F., Hougaard, P., De Beaufort, C., Castao, L., Mortensen, H. B., Lernmark, A., & Hansen, L. (December 2011). Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity, 44 (8), 616-623. doi:10.3109/08916934.2011.576724 Peer reviewed |
Kusters, D. M., De Beaufort, C., Widhalm, K., Guardamagna, O., Bratina, N., Ose, L., & Wiegman, A. (26 September 2011). Paediatric screening for hypercholesterolaemia in Europe. Archives of Disease in Childhood, 97 (3), 272-276. doi:10.1136/archdischild-2011-300081 Peer Reviewed verified by ORBi |
Nielsen, L. B., Pörksen, S., Andersen, M. L., Fredheim, S., Svensson, J., Hougaard, P., Vanelli, M., Åman, J., Mortensen, H. B., Hansen, L., & De Beaufort, C. (23 March 2011). The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes. BMC Medical Genetics, 12 (41). doi:10.1186/1471-2350-12-41 Peer Reviewed verified by ORBi |
Akerblom, H. K., Krischer, J., Virtanen, S., Berseth, C., Becker, D., Dupré, J., Ilonen, J., Trucco, M., Savilahti, E., Koski, K., Pajakkala, E., Fransiscus, M., Lough, G., Bradley, B., Koski, M., Knip, M., & De Beaufort, C. (March 2011). The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia, 54 (3), 627-633. doi:10.1007/s00125-010-1964-9 Peer Reviewed verified by ORBi |
Descamps, O. S., Tenoutasse, S., Stephenne, X., Gies, I., Beauloye, V., Lebrethon, M.-C., De Beaufort, C., De Waele, K., Scheen, A., Rietzschel, E., Mangano, A., Panier, J. P., Ducobu, J., Langlois, M., Balligand, J.-L., Legat, P., Blaton, V., Muls, E., Van Gaal, L., ... Heller, F. R. (2011). Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis, 218 (2), 272-280. doi:10.1016/j.atherosclerosis.2011.06.016 Peer reviewed |
Hanas, R., De Beaufort, C., Hoey, H., & Anderson, B. (2011). Insulin delivery by injection in children and adolescents with diabetes. Pediatric Diabetes, 12 (5), 518-526. doi:10.1111/j.1399-5448.2010.00731.x Peer reviewed |
Cardwell, C. R., Stene, L. C., Joner, G., Bulsara, M. K., Cinek, O., Rosenbauer, J., Ludvigsson, J., Svensson, J., Goldacre, M. J., Waldhoer, T., Jarosz-Chobot, P., Gimeno, S. G., Chuang, L.-M., Roberts, C. L., Parslow, R. C., Wadsworth, E. J., Chetwynd, A., Brigis, G., Urbonaite, B., ... Patterson, C. C. (2011). Birth order and childhood type 1 diabetes risk: A pooled analysis of 31 observational studies. International Journal of Epidemiology, 40 (2), 363-374. doi:10.1093/ije/dyq207 Peer reviewed |
Conget, I., Battelino, T., Giménez, M., Gough, H., Castañeda, J., Bolinder, J., & De Beaufort, C. (Other coll.). (January 2011). The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technology and Therapeutics, 13 (1), 49-54. doi:10.1089/dia.2010.0107 Peer Reviewed verified by ORBi |
De Beaufort, C., Jarosz-Chobot, P., Frank, M., de Bart, J., & Deja, G. (2010). Transition from pediatric to adult diabetes care: Smooth or slippery? Pediatric Diabetes, 11 (1), 24-27. doi:10.1111/j.1399-5448.2009.00524.x Peer reviewed |
Pörksen, S., Laborie, L. B., Nielsen, L., Louise Max Andersen, M., Sandal, T., de Wet, H., Schwarcz, E., Åman, J., Swift, P., Kocova, M., Schönle, E. J., De Beaufort, C., Hougaard, P., Ashcroft, F., Molven, A., Knip, M., Mortensen, H. B., Hansen, L., & Njølstad, P. R. (2010). Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies. BMC Endocrine Disorders, 10. doi:10.1186/1472-6823-10-16 Peer Reviewed verified by ORBi |
Swift, P. G. F., Skinner, T. C., De Beaufort, C., Cameron, F. J., Åman, J., Aanstoot, H.-J., Castaño, L., Chiarelli, F., Daneman, D., Danne, T., Dorchy, H., Hoey, H., Kaprio, E. A., Kaufman, F., Kocova, M., Mortensen, H. B., Njølstad, P. R., Phillip, M., Robertson, K. J., ... Skovlund, S. E. (2010). Target setting in intensive insulin management is associated with metabolic control: The Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005. Pediatric Diabetes, 11 (4), 271-278. doi:10.1111/j.1399-5448.2009.00596.x Peer reviewed |
Mortensen, H. B., Swift, P. G., Holl, R. W., Hougaard, P., Hansen, L., Bjoerndalen, H., De Beaufort, C., & Knip, M. (2010). Multinational study in children and adolescents with newly diagnosed type 1 diabetes: Association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatric Diabetes, 11 (4), 218-226. doi:10.1111/j.1399-5448.2009.00566.x Peer reviewed |
Van Esso, D., Del Torso, S., Hadjipanayis, A., Biver, A., Jaeger-Roman, E., Wettergren, B., Nicholson, A., Zach, M., Hamilton, P., Tenore, A., Ramet, J., Craft, A., Pulido, M., Azevedo, I., Barak, S., Barillari, A., Bovet, F., Chybicka, A., De Beaufort, C., ... Verloove Vanhorick, P. (2010). Paediatric primary care in Europe: Variation between countries. Archives of Disease in Childhood, 95 (10), 791-795. doi:10.1136/adc.2009.178459 Peer reviewed |
Scheen, A. J., Bourguignon, J. P., Guillaume, M., Böhme, P., Collin, J. F., De Beaufort, C., Hubermont, G., Lair, M. L., Michel, G., Romain, M.-L., & Ziegler, O. (2010). L'éducation thérapeutique: Une solution pour vaincre l'inertie clinique et le défaut d'observance. Revue Medicale de Liege, 65 (5-6), 250-255. Peer reviewed |
Åman, J., Skinner, T. C., De Beaufort, C., Swift, P. G. F., Aanstoot, H.-J., Cameron, F., Martul, P., Chiarelli, F., Daneman, D., Danne, T., Dorchy, H., Hoey, H., Kaprio, E. A., Kaufman, F., Kocova, M., Mortensen, H. B., Njølstad, P. R., Phillip, M., Robertson, K. J., ... Ackerman, R. W. (2009). Associations between physical activity, sedentary behavior, and glycemic control in a large cohort of adolescents with type 1 diabetes: The Hvidoere Study Group on Childhood Diabetes. Pediatric Diabetes, 10 (4), 234-239. doi:10.1111/j.1399-5448.2008.00495.x Peer reviewed |
Biason-Lauber, A., Konrad, D., Meyer, M., De Beaufort, C., & Schoenle, E. J. (2009). Ovaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 gene. American Journal of Human Genetics, 84 (5), 658-663. doi:10.1016/j.ajhg.2009.03.016 Peer Reviewed verified by ORBi |
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., Soltész, G., & De Beaufort, C. (Other coll.). (2009). Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study Lancet. The Lancet, 373 (9680), 2027-2033. doi:10.1016/S0140-6736(09)60568-7 Peer Reviewed verified by ORBi |
Mortensen, H. B., Hougaard, P., Swift, P., Hansen, L., Holl, R. W., Hoey, H., Bjoerndalen, H., De Beaufort, C., Chiarelli, F., Danne, T., Schoenle, E. J., & Åman, J. (2009). New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care, 32 (8), 1384-1390. doi:10.2337/dc08-1987 Peer reviewed |
Pfleger, C., Kaas, A., Hansen, L., Alizadeh, B., Hougaard, P., Holl, R., Holb, H., Roep, B. O., Mortensen, H. B., Schloot, N. C., & De Beaufort, C. (Other coll.). (July 2008). Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes. Clinical Immunology, 128 (1), 57-65. doi:10.1016/j.clim.2008.03.458 Peer Reviewed verified by ORBi |
Pfleger, C., Mortensen, H. B., Hansen, L., Herder, C., Roep, B. O., Hoey, H., Aanstoot, H. J., Kocova, M., Schloot, N. C., & De Beaufort, C. (Other coll.). (April 2008). Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes, 57 (4), 929-937. doi:10.2337/db07-1697 Peer Reviewed verified by ORBi |
Lagrou, K., Froidecoeur, C., Thomas, M., Massa, G., Beckers, D., Craen, M., De Beaufort, C., Rooman, R., François, I., Heinrichs, C., Lebrethon, M. C., Thiry-Counson, G., Maes, M., & De Schepper, J. (2008). Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age. Hormone Research, 69 (6), 334-342. doi:10.1159/000117389 Peer reviewed |
Cardwell, C. R., Stene, L. C., Joner, G., Cinek, O., Svensson, J., Goldacre, M. J., Parslow, R. C., Pozzilli, P., Brigis, G., Stoyanov, D., Urbonaite, B., Sipetic, S., Schober, E., Ionescu-Tirgoviste, C., Devoti, G., De Beaufort, C., Buschard, K., & Patterson, C. C. (2008). Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia, 51 (5), 726-35. doi:10.1007/s00125-008-0941-z Peer reviewed |
De Beaufort, C. (2008). Continuing stability of center differences in pediatric diabetes care: Do advances in diabetes treatment improve outcome? the hvidoere study group on childhood diabetes [letter to the editor]. Diabetes Care, 31 (4). doi:10.2337/dc08-0030 Peer reviewed |
Cameron, F. J., Skinner, T. C., De Beaufort, C., Hoey, H., Swift, P. G. F., Aanstoot, H., Åman, J., Martul, P., Chiarelli, F., Daneman, D., Danne, T., Dorchy, H., Kaprio, E. A., Kaufman, F., Kocova, M., Mortensen, H. B., Njølstad, P. R., Phillip, M., Robertson, K. J., ... Skovlund, S. E. (2008). Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabetic Medicine: A Journal of the British Diabetic Association, 25 (4), 463-468. doi:10.1111/j.1464-5491.2008.02399.x Peer reviewed |
Nielsen, L. B., Ploug, K. B., Swift, P., Ørskov, C., Jansen-Olesen, I., Chiarelli, F., Holst, J. J., Hougaard, P., Pörksen, S., Holl, R., De Beaufort, C., Gammeltoft, S., Rorsman, P., Mortensen, H. B., & Hansen, L. (2007). Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes. European Journal of Endocrinology, 156 (6), 663-671. doi:10.1530/EJE-06-0756 Peer reviewed |
Phillip, M., Battelino, T., Rodríguez, H., Danne, T., Kaufman, F., & De Beaufort, C. (Other coll.). (2007). Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 30 (6), 1653. doi:10.2337/dc07-9922 Peer Reviewed verified by ORBi |
Krischer, J., & De Beaufort, C. (Other coll.). (2007). Study design of the Trial to Reduce IDDM in the Genetically Risk (TRIGR). Pediatric Diabetes, 8, 117-137. Peer Reviewed verified by ORBi |
Lagrou, K., Vanderfacillic, J., Froidecoeur, C., Thomas, M., Massa, G., Tenoutasse, S., Craen, M., Lebrethon, M. C., Beckers, D., Francois, I., Rooman, R., Thiry-Counson, G., De Beaufort, C., & De Schepper, J. (2007). Effect of 2 years of high-dose growth hormone therapy on cognitive and psychological development in short children born small for gestational age. European Journal of Endocrinology, 156 (2), 195-201. doi:10.1530/eje.1.02335 Peer reviewed |
De Beaufort, C., Swift, P. G. F., Skinner, C. T., Aanstoot, H. J., Aman, J., Cameron, F., Martul, P., Chiarelli, F., Daneman, D., Danne, T., Dorchy, H., Hoey, H., Kaprio, E. A., Kaufman, F., Kocova, M., Mortensen, H. B., Njolstad, P. R., Phillip, M., Robertson, K. J., ... Vanelli, M. (2007). Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care, 30 (9), 2245-50. doi:10.2337/dc07-0475 Peer Reviewed verified by ORBi |
Akerblom, H. K., Knip, M., Becker, D., Dosch, Dupré, J., Ilonen, J., Krischer, J. P., & De Beaufort, C. (Other coll.). (2007). The TRIGR Trial: Testing the Potential Link between Weaning Diet and Type 1 Diabetes. Immunology, Endocrine and Metabolic Agents - Medicinal Chemistry, 7, 251-263. doi:10.2174/187152207780832315 Peer Reviewed verified by ORBi |
De Beaufort, C., & Swift, P. (08 July 2006). Support for young people with diabetes. The BMJ, 333 (7558), 55-56. doi:10.1136/bmj.333.7558.55 Peer reviewed |
Nielsen, L. B., Mortensen, H. B., Chiarelli, F., Holl, R., Swift, P., De Beaufort, C., Pociot, F., Hougaard, P., Gammeltoft, S., Knip, M., & Hansen, L. (2006). Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: Reduced insulin antibody titres and preserved beta cell function. Diabetologia, 49 (1), 71-74. doi:10.1007/s00125-005-0042-1 Peer reviewed |
Sagen, J. V., Odili, S., Bjorkhaug, L., Zelent, D., Buettger, C., Kwagh, J., Stanley, C., Dahl-Jorgensen, K., De Beaufort, C., Bell, G. I., Han, Y., Grimsby, J., Taub, R., Molven, A., Sovik, O., Njolstad, P. R., & Matschinsky, F. M. (2006). From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes, 55 (6), 1713-22. doi:10.2337/db05-1513 Peer reviewed |
Vits, L., Beckers, D., Craen, M., De Beaufort, C., Vanfleteren, E., Dahan, K., Nollet, A., Vanhaverbeke, G., Imschoot, S. V., Bourguignon, J.-P., Beauloye, V., Storm, K., Massa, G., Giri, M., Nobels, F., De Schepper, J., Rooman, R., Van den Bruel, A., Mathieu, C., & Wuyts, W. (2006). Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients [1] [letter to the editor]. Clinical Genetics, 70 (4), 355-359. doi:10.1111/j.1399-0004.2006.00686.x Peer reviewed |
De Beaufort, C., Beck, P., Seligmann, R., de Meirleir, L., & de Schepper, J. (2006). Acute pancreatitis after growth hormone treatment: disease or treatment linked? European Journal of Pediatrics, 12. doi:10.1007/s00431-006-0126-z Peer Reviewed verified by ORBi |
Perquin, M., Keipes, M., Wirion, R., Haas, N., De Beaufort, C., & Michel, G. H. (2006). Evolution du traitement médicamenteux du diabète au Luxembourg. Bulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg, (1), 29-35. Peer Reviewed verified by ORBi |
De Beaufort, C. (Other coll.). (2006). Incidence and trends of Childhood Type 1 diabetes worldwide 1990-1999. Diabetic Medicine: A Journal of the British Diabetic Association, 23 (8), 857-866. doi:10.1111/j.1464-5491.2006.01925.x Peer Reviewed verified by ORBi |
Danne, T., Battelino, T., Kordonouri, O., Hanas, R., Klinkert, C., Ludvigsson, J., Barrio, R., Aebi, C., Gschwend, S., Mullis, P., Schumacher, U., Schwitzgebel, V., Zumsteg, U., Morandi, A., Rabbone, I., Cherubini, V., Toni, S., De Beaufort, C., Hindmarsh, P., ... Phillip, M. (2005). A cross-sectional international survey of continuous subcutaneous insulin infusion (CSII) in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatric Diabetes, 6, 193-198. doi:10.1111/j.1399-543X.2005.00131.x Peer Reviewed verified by ORBi |
Perquin, M., Michel, G. H., De Beaufort, C., Keipes, M., Wirion, R., & Haas, N. (2005). Changes in diabetes prevalence and treatment in the last ten years in Luxembourg. A lesson from the United Kingdom prospective diabetes study? Diabetes and Metabolism, 31 (5), 499-502. doi:10.1016/S1262-3636(07)70222-7 Peer reviewed |
De Beaufort, C., Reunanen, A., Raleigh, V., Storms, F., Kleinebreil, L., Gallego, R., Giorda, C., Midthjell, K., Jecht, M., De Leeuw, I., Schober, E., Boran, G., & Tolis, G. (2003). European Union diabetes indicators: Fact or fiction? European Journal of Public Health, 13 (3 SUPPL.), 51-54. doi:10.1093/eurpub/13.suppl_3.51 Peer reviewed |
Ronningen, K. S., Keiding, N., Green, A., & De Beaufort, C. (Other coll.). (2001). Correlations between the incidence of childhood onset type 1 diabetes in Europe and HLA genotypes. Diabetologia, 44 (3), 51-B59. doi:10.1007/pl00002955 Peer Reviewed verified by ORBi |
McKinney, P. A., & De Beaufort, C. (Other coll.). (2001). Seasonality of birth in patients with childhood type 1 diabetes in nineteen European regions. Diabetologia, 44 (3), 67-B74. doi:10.1007/pl00002957 Peer Reviewed verified by ORBi |
Hilger, C., Grigioni, F., De Beaufort, C., Michel, G., Freilinger, J., & Hentges, F. (2001). Differential binding of IgG and IgA antibodies to antigenic determinants of bovine serum albumin. Clinical and Experimental Immunology, 123 (3), 387-394. doi:10.1046/j.1365-2249.2001.01451.x Peer reviewed |
Krstevska-Konstantinova, M., Charlier, C., Craen, M., Du Caju, M., Heinrichs, C., De Beaufort, C., Plomteux, G., Bourguignon, J. P., Lynge, E., Kulin, H., Russo, J., Gray, E., Møller, H., Brock, J., Sharpe, R., Bjerregaard, P., & Vom Saal, F. (2001). Sexual precocity after immigration from developing countries to Belgium: Evidence of previous exposure to organochlorine pesticides. Human Reproduction, 16 (103), 1020-1026. doi:10.1093/humrep/16.5.1020 Peer Reviewed verified by ORBi |
Green, A., Patterson, C. C., & De Beaufort, C. (Other coll.). (2001). Trends in the incidence of childhood onset diabetes in Europe. 1989-1998. Diabetologia, 44 (3), 3-B8. doi:10.1007/pl00002950 Peer Reviewed verified by ORBi |
Levy-Marchal, C., Patterson, C. C., Green, A., & De Beaufort, C. (Other coll.). (2001). Geographical variation of presentation at diagnosis of type 1 diabetes in children: the EURODIAB Study. Diabetologia, 44 (3), 75-B80. doi:10.1007/pl00002958 Peer Reviewed verified by ORBi |
Patterson, C. C., Dahlquist, G., Soltesz, G., Green, A., & De Beaufort, C. (Other coll.). (2001). Is childhood onset type1 diabetes a wealth-related disease. An ecological analysis of European incidence rates. Diabetologia, 44, 9 – B16. doi:10.1007/PL00002961 Peer Reviewed verified by ORBi |
De Beaufort, C. (Other coll.). (2000). Decreased prevalence of atopic diseases in children with diabetes. Journal of Pediatrics, 137, 470-474. doi:10.1067/mpd.2000.109109 Peer Reviewed verified by ORBi |
De Beaufort, C. (Other coll.). (2000). The Eurodiab Substudy 2 study group. Infections and vaccinations as risk factors for childhood type1(insulin dependent) diabetes mellitus: a multicentre case control investigation. Diabetologia, 43, 47-53. Peer Reviewed verified by ORBi |
De Beaufort, C. (Other coll.). (2000). Variation and trends in incidence of childhood diabetes in Europe. The Lancet, 355, 873-876. doi:10.1016/S0140-6736(99)07125-1 Peer Reviewed verified by ORBi |
De Beaufort, C., Schneider, F., Chafai, R., Colette, J. M., Delneste, D., & Pierguin, G. (2000). Diaphragmatic hernia and Fryns syndrome phenotype in partial trisomy 22. Genetic Counseling, 11 (2), 181-182. Peer Reviewed verified by ORBi |
De Beaufort, C. (Other coll.). (1999). The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia, 42 (1), 51-55. Peer Reviewed verified by ORBi |
Dahlquist, G. G., Patterson, C., Soltesz, G., & De Beaufort, C. (Other coll.). (1999). Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care, 22 (10), 1698-1702. doi:10.2337/diacare.22.10.1698 Peer Reviewed verified by ORBi |
De Beaufort, C. (March 1998). Hypoglycemia during intensified insulin therapy of young children. Journal of Pediatric Endocrinology and Metabolism, 11 (1), 153-158. doi:10.1515/JPEM.1998.11.S1.153 Peer Reviewed verified by ORBi |
De Beaufort, C. (Other coll.). (1998). Familial risk of type 1 diabetes in European children. Diabetologia, 41, 1151-1156. Peer Reviewed verified by ORBi |
Humbel, R. L., Guillaume, A. C., Schmit, P., Gilson, G., De Beaufort, C., Michel, G., & Mauch, L. (1997). Etude de differentes methodes pour la mise en evidence des autoanticorps anti-glutamate-decarboxylase associes au developpement du diabete insulinodependant. Immuno-Analyse et Biologie Specialisee, 12 (5), 275-279. doi:10.1016/S0923-2532(97)86628-8 Peer reviewed |
Batstra, M. R., Pina, M., Quan, J., Mulder, P., De Beaufort, C., Bruining, G. J., & Aanstoot, H.-J. (1997). Fluctuations in GAD65 antibodies after clinical diagnosis of IDDM in young children. Diabetes Care, 20 (4), 642-644. doi:10.2337/diacare.20.4.642 Peer reviewed |
Hentges, F. R., Michel, G. H., Hoffmann, A. J., De Beaufort, C., Thill, R. R., Wirion, R. P., Thill, M. J., & Glaesener, G. M. (1996). MHC-genotyping of IDDM patients in Luxembourg. Evidence for a pediatric patient subgroup. Bulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg, 133 (1), 5-12. Peer Reviewed verified by ORBi |
De Beaufort, C., Sodoyez, J. C., Koch, M., Bruining, G. J., & Sodoyez-Goffaux, F. (1993). Insulin autoantibodies and immune response to human insulin therapy in 24 type 1 (insulin-dependent) diabetic children: superiority of radio binding assay over solid phase assay. Diabetes Research and Clinical Practice, 21 (1), 19-24. doi:10.1016/0168-8227(93)90092-J Peer reviewed |
Karvonen, M., Tuomilehto, J., Libman, J., laporte, R., & De Beaufort, C. (Other coll.). (1993). A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin dependent) diabetes mellitus. Diabetologia, 36, 883-892. doi:10.1007/BF02374468 Peer Reviewed verified by ORBi |
Papoz, L., & De Beaufort, C. (Other coll.). (1993). Utilization of drug sales data for the epidemiology of chronic diseases: the example of diabetes. Epidemiology, 4, 421-426. doi:10.1097/00001648-199309000-00007 Peer Reviewed verified by ORBi |
Greenbaum, C. J., Palmer, J. P., Kuglin, B., Kolb, H., & De Beaufort, C. (1992). Insulin autoantibodies measured by radio immunoassay methodology are more related to insulin dependent diabetes than those measured by enzyme-linked immunosorbent assay : results of the fourth workshop on the standardisation of insulin autoantibodv measurement. Journal of Clinical Endocrinology and Metabolism, 74, 1040-1044. doi:10.1210/jcem.74.5.1569152 Peer reviewed |
Green, A., Patterson, C. C., Gale, E. A., & De Beaufort, C. (Other coll.). (1992). Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. The Lancet, 339 (8798), 905-909. doi:10.1016/0140-6736(92)90938-Y Peer Reviewed verified by ORBi |
De Beaufort, C. (1992). Nicotinamid. Diabetes, prevention and therapy, 6, 17. Peer reviewed |
Levy-Marchal, C., Papoz, L., De Beaufort, C., Doutreix, J., Froment, V., Voirin, J., & Czernichow, P. (1992). Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabetic Medicine: A Journal of the British Diabetic Association, 9, 279-284. doi:10.1111/j.1464-5491.1992.tb01777.x Peer Reviewed verified by ORBi |
De Beaufort, C., Cecchi-Tenerini, R., Clerc, R., Hilaire, M., Schwartz, F., & Manciaux, M. (1991). Prévalence du diabète insulino-dépendant chez les enfants scolarisés de 6 a 16 ans en Lorraine. Archives Françaises de Pédiatrie, 48, 227-228. Peer Reviewed verified by ORBi |
De Beaufort, C., Cecchi-Tenerini, R., Clerc, R., Hilaire, M., Schwartz, F., & Manciaux, M. (1991). Incidence of insulin dependent diabetes in children of school age in Lorraine [letter to the editor]. Archives Françaises de Pédiatrie, 48 (3), 228. Peer Reviewed verified by ORBi |
De Beaufort, C., Michel, G., Haas, N., & Glaesener, G. (1991). Utilisation de médicaments anti-diabétiques au Grand Duché de Luxembourg. Bulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg, 2, 5-9. Peer Reviewed verified by ORBi |
Levy-Marchal, C., Pappoz, L., De Beaufort, C., Doutreix, J., Froment, V., Voirin, J., & Czernichow, P. (1991). Incidence du diabète insulino-dépendant, survenant avant l’âge de 20 ans en France. Pédiatrie, 46, 367-371. Peer Reviewed verified by ORBi |
De Beaufort, C. (1990). Neuropathie. In P. F. Bougnères, J. Jos, ... J. L. Chaussain (Eds.), Le diabète de l'enfant (Médecine-Science). Paris, France: Flammarion. Peer reviewed |
Slijper, F. M. E., De Beaufort, C., Bruining, G. J., De Visser, J. J., Aarsen, R. S. R., Kicken, D. A. M., & Van Strik, R. (1990). Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: Evaluation after two years of therapy [IMPACT PSYCHOLOGIQUE D'UN TRAITEMENT PAR PERFUSION SOUS-CUTANEE CONTINUE D'INSULINE DES LE DIAGNOSTIC CHEZ LES ENFANTS DIABETIQUES NON SELECTIONNES: EVALUATIONS APRES DEUX AND DE TRAITEMENT]. Diabète et Métabolisme, 16 (4), 273-277. Peer Reviewed verified by ORBi |
Levy-Marchal, C., Papoz, L., De Beaufort, C., Doutreix, J., Froment, V., Voirin, J., Collignon, A., Garros, B., Schleret, Y., & Czernichow, P. (1990). Incidence of juvenile type 1 (insulin dependent) diabetes mellitus in France. Diabetologia, 33, 465-469. doi:10.1007/BF00405107 Peer Reviewed verified by ORBi |
Slijper, F. M. E., De Beaufort, C., Bruining, G. J., De Visser, J. J., Aarsen, R. S. R., Kicken, D. A. M., & Van Strik, R. (1990). Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: Evaluation after two years of therapy [IMPACT PSYCHOLOGIQUE D'UN TRAITEMENT PAR PERFUSION SOUS-CUTANEE CONTINUE D'INSULINE DES LE DIAGNOSTIC CHEZ LES ENFANTS DIABETIQUES NON SELECTIONNES: EVALUATIONS APRES DEUX AND DE TRAITEMENT]. Diabète et Métabolisme, 16 (4), 273-277. Peer Reviewed verified by ORBi |
Kolb, H., Arnaiz-Villena, A., De Beaufort, C., Becker, D., Becker, F., Betterle, C., Bosi, E., Colman, P., Dean, E. B., Eisenbarth, G. S., Elliott, R. B., Gorus, F., Hübinger, A., Karjalainen, J., Keilacker, H., Kwan, J., Levy-Marchal, C., Maclaren, N., Palmer, J. P., ... Ziegler, A.-G. (1990). The Fourth International Workshop on the Standardisation of Insulin Autoantibody Measurement. Diabetologia, 33 (10), 638-639. doi:10.1007/BF00400213 Peer reviewed |
Colle, E., Lounamaa, R., Tuomilehto, J., De Beaufort, C., Balzano, E., Bruno, G., Cacciari, E., Cerutti, F., Chiarelli, F., & Chiumello, G. (1990). 17 The epidemiology and immunogenetics of IDDM in Italian-heritage populations. Diabetes Epidemiology Research International (DERI) Study Group. Diabetes/Metabolism Reviews, 6, 63-69. doi:10.1002/dmr.5610060201 Peer Reviewed verified by ORBi |
De Beaufort, C., & Bruining, G. J. (1989). Evolution du diabète sucré insulino-dépendant dans les deux premières années. In P. Czernichow & H. Dorchy (Eds.), Traité de diabétologie. Paris, France: Doin. Peer reviewed |
De Beaufort, C., André, J.-L., Heimans, J. J., van der Eerden, H. A. M., van Diemen, N. G. J., Duc, M.-L., & Pierson, M. (1989). Peripheral nerve function in children with end-stage renal failure. Pediatric Nephrology, 3 (2), 175-178. doi:10.1007/BF00852903 Peer reviewed |
Van Wirdum, E., van Best, J., Bruining, G. J., De Beaufort, C., & Oosterhuis, J. (1989). Blood-retinal and blood-aqueous barrier permeability, lens autofluorescence and transmission in insulin-dependent diabetic youngsters. Graefe's Archive of Clinical & Experimental Ophthalmology, 227 (1), 26-19. doi:10.1007/BF02169820 Peer reviewed |
De Beaufort, C., Houtzagers, C. M. G. J., Bruining, G. J., Aarsen, R. S. R., den Boer, N. C., Grose, W. F. A., van Strik, R., & de Visser, J. J. (1989). Continuous subcutaneous insulin infusion (CSII) versus conventional insulin injection therapy in newly diagnosed diabetic children : a randomised prospective trial. Diabetic Medicine: A Journal of the British Diabetic Association, 6, 766-771. doi:10.1111/j.1464-5491.1989.tb01276.x Peer Reviewed verified by ORBi |
De Beaufort, C., Michel, G., & Glaesener, G. (1988). The incidence of Type 1 (insulin-dependent) diabetes mellitus in subjects aged 0-19 years in Luxembourg: a retrospective study from 1977 to 1986. Diabetologia, 31 (10), 758-761. doi:10.1007/BF00274779 Peer reviewed |
De Beaufort, C., Den Boer, N. C., Bruining, G. J., Eilers, G. A. M., Van Strik, R., & Weterings, T. (1988). Urinary C-peptide: A useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood. Annals of Clinical Biochemistry, 25 (5), 552-559. doi:10.1177/000456328802500513 Peer Reviewed verified by ORBi |
De Beaufort, C., Binder, C., Bruining, G. J., Den Boer, N. C., & Van Strik, R. (1988). Insulin antibodies in diabetic children before treatment: A marker for islet B-cell destruction? Diabetic Medicine: A Journal of the British Diabetic Association, 5 (5), 441-443. doi:10.1111/j.1464-5491.1988.tb01024.x Peer reviewed |
Baekkeskov, S., Landin, M., Kristensen, J. K., Srikanta, S., Bruining, G. J., Mandrup-Poulsen, T., De Beaufort, C., Soeldner, J. S., Eisenbarth, G., & Lindgren, F. (1987). Antibodies to a 64,000 M(r) human islet cell antigen precede the clinical onset of insulin-dependent diabetes. Journal of Clinical Investigation, 79 (3), 926-934. doi:10.1172/JCI112903 Peer reviewed |
De Beaufort, C., & Bruining, G. J. (1987). Continuous subcutaneous insulin infusion in children. Diabetic Medicine: A Journal of the British Diabetic Association, 4 (2), 103-108. doi:10.1111/j.1464-5491.1987.tb00842.x Peer reviewed |
Heimans, J. J., Bertelsmann, F. W., De Beaufort, C., Faber, Y. A., & Bruining, G. J. (1987). Quantitative sensory examination in diabetic children: Assessment of thermal discrimination. Diabetic Medicine: A Journal of the British Diabetic Association, 4 (3), 251-253. doi:10.1111/j.1464-5491.1987.tb00874.x Peer reviewed |
De Beaufort, C., Bruining, G. J., Home, P. D., Houtzagers, C. M. G. J., & van Strik, R. (1986). Overnight metabolic profiles in very young insulin-dependent diabetic children. European Journal of Pediatrics, 145 (1-2), 73-76. doi:10.1007/BF00441859 Peer reviewed |
Ludvigsson, J., Samuelson, U., De Beaufort, C., Deschamps, I., François, R., Herz, G., New, M., Orchard, T., & Schober, E. (1986). HLA Dr3 is associated with a more slowly progressive form of IDDM. Diabetologia, 29, 207-210. doi:10.1007/BF00454876 Peer Reviewed verified by ORBi |
De Beaufort, C., Bruining, G. J., Aarsen, R. S. R., den Boer, Grose, W. F. A., & van Strik, R. (1986). The influence of continuous subcutaneous insulin infusion on the remission period in IDDM. Pediatric and Adolescent Endocrinology, 15. Peer reviewed |
Bruining, C. J., De Beaufort, C., & Houtzagers, C. M. G. J. (1986). Schedule on self blood glucose monitoring in children under 6 years of age. Pediatric and Adolescent Endocrinology, (15). Peer reviewed |
De Beaufort, C., Bruining, G. J., Aarsen, R. S. R., den Boer, N. C., & Grose, W. F. (1985). Does continuous subcutaneous insulin infusion (CSII) prolong the remission phase of insulin-dependent diabetic children? Preliminary findings of a randomized prospective study. Netherlands Journal of Medicine, 28 (SUPPL. 1), 53-54. Peer Reviewed verified by ORBi |